Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
From MaRDI portal
Publication:3465385
Recommendations
- Bayesian randomized clinical trials: A decision-theoretic sequential design
- A Bayesian Approach to the Design of Phase II Clinical Trials
- Comparison of dichotomized and distributional approaches in rare event clinical trial design: a fixed Bayesian design
- Bayesian design of clinical trials using joint cure rate models for longitudinal and time-to-event data
- An optimal Bayesian predictive probability design for phase II clinical trials with simple and complicated endpoints
- Bayesian designs for phase I--II clinical trials
- A Bayesian adaptive design for clinical trials in rare diseases
- Bayesian Design and Analysis of Two x Two Factorial Clinical Trials
Cites work
- A simulation-based approach to Bayesian sample size determination for performance under a given model and for separating models
- Bayesian design of noninferiority trials for medical devices using historical data
- Bayesian meta-experimental design: evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes
- Commensurate priors for incorporating historical information in clinical trials using general and generalized linear models
- Robust Covariate‐Adjusted Log‐Rank Statistics and Corresponding Sample Size Formula for Recurrent Events Data
Cited in
(3)
This page was built for publication: Bayesian design of superiority clinical trials for recurrent events data with applications to bleeding and transfusion events in myelodyplastic syndrome
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3465385)